Cartesian Therapeutics Files 2024 10-K
Ticker: RNAC · Form: 10-K · Filed: Mar 13, 2025 · CIK: 1453687
| Field | Detail |
|---|---|
| Company | Cartesian Therapeutics, Inc. (RNAC) |
| Form Type | 10-K |
| Filed Date | Mar 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceutical
TL;DR
Cartesian Therapeutics filed its 2024 10-K, detailing FY24 performance.
AI Summary
Cartesian Therapeutics, Inc. filed its 2024 10-K on March 13, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Selecta Biosciences Inc. until January 9, 2009, is based in Frederick, MD. Key financial data and operational details for the fiscal year are presented in this comprehensive filing.
Why It Matters
This filing provides investors and stakeholders with a detailed overview of Cartesian Therapeutics' financial health, operational performance, and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Cartesian Therapeutics is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024 — Fiscal Year (The period covered by the 10-K filing.)
- 2023-12-31 — Previous Year End (Comparison point for financial performance.)
- 2025-03-13 — Filing Date (Date the 10-K was submitted to the SEC.)
Key Players & Entities
- Cartesian Therapeutics, Inc. (company) — Filer of the 10-K
- Selecta Biosciences Inc. (company) — Former company name
- 2024-12-31 (date) — Fiscal year end
- 2025-03-13 (date) — Filing date
- Frederick, MD (location) — Company business address
FAQ
What is the primary business of Cartesian Therapeutics, Inc.?
Cartesian Therapeutics, Inc. is classified under Pharmaceutical Preparations (SIC code 2834).
When did Cartesian Therapeutics, Inc. change its name from Selecta Biosciences Inc.?
The company changed its name from Selecta Biosciences Inc. on January 9, 2009.
What is the business address of Cartesian Therapeutics, Inc.?
The business address is 7495 New Horizon Way, Frederick, MD 21703.
What is the SEC file number for Cartesian Therapeutics, Inc.?
The SEC file number is 001-37798.
What fiscal year does this 10-K filing cover?
This 10-K filing covers the fiscal year ending December 31, 2024.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 13, 2025 regarding Cartesian Therapeutics, Inc. (RNAC).